Devon Energy Corp vs GeneDx Holdings Corp — how do they compare? Devon Energy Corp trades at $43.12 (market cap $49.52B), while GeneDx Holdings Corp trades at $61.39 (market cap $1.96B). The key difference: Devon Energy Corp is far larger — about 25.3× GeneDx Holdings Corp's market cap, and Devon Energy Corp pays a 2.42% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| DVN | WGS | |
|---|---|---|
Market Cap | $49.52B | $1.96B |
Sector | Energy | Technology |
52-Week High | $52.07 | $167.51 |
52-Week Low | $31.74 | $34.51 |
Enterprise Value | $56.29B | $1.96B |
Dividend Yield | 2.42% | — |
Signals from Pluang's Aura AI — not financial advice
Devon Energy (DVN) trades at $43.35, down 0.12% on the day, with a neutral technical signal and bullish moving averages. The stock shows strong fundamentals with a P/E of 11.96, net income margin of 13.71%, and consistent cash flow generation. Recent news highlights activist pressure for asset sales and the integration benefits from the Coterra acquisition, targeting $2 billion in synergies by 2027.
DVN presents a compelling value opportunity with analyst consensus bullish (71% buy ratings) and a price target of $60.18, implying 39% upside. Risks include volatile energy prices, execution of merger synergies, and activist investor demands. Earnings growth and free cash flow remain key catalysts for shareholder returns.
WGS trades at $62.73, up 0.48% on the day, amid a bearish technical signal and negative earnings momentum. The stock faces significant headwinds from a class action lawsuit alleging securities fraud tied to a 49% stock decline, while fundamentals show a net loss of $21.02 million in 2025 and deteriorating profitability into 2026. Analyst consensus remains bullish with a $75.40 price target, but recent news flow is overwhelmingly negative.
The outlook is clouded by legal risks and weak financial performance, though analyst optimism suggests potential recovery if the company can stabilize operations. Key risks include litigation outcomes, execution on profitability, and market sentiment shifts. The stock's trajectory hinges on resolving legal challenges and demonstrating sustainable earnings improvement.
Trailing returns across standard periods
Latest headlines on both assets
Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2021, Devon's proved reserves totaled 1.6 billion barrels of oil equivalent, and net production that year was 572 thousand boe/d, of which oil and natural gas liquids made up 74% of production, with natural gas accounting for the remainder.
Read more on DVN →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →